Description
OSI-027isaninhibitorofmTORC1/2thatexhibitsanticancerchemotherapeuticactivity.Invitro,OSI0027inhibitsphosphorylationofdownstreamtargetAkt,inhibitingcellproliferationinbreastcancercells.OSI-027alsoinducesapoptosisinseverallymphoidcelllinesincludingmantlecelllymphoma,acutelymphocyticleukemia(ALL),andothers.Inanimalmodelsofcancer,thiscompoundinhibitstumorgrowth.
References
LiH,LinJ,WangX,etal.TargetingofmTORC2preventscellmigrationandpromotesapoptosisinbreastcancer.BreastCancerResTreat.2012Aug;134(3):1057-66.PMID:22476852.
GuptaM,HendricksonAE,YunSS,etal.DualmTORC1/mTORC2inhibitiondiminishesAktactivationandinducesPuma-dependentapoptosisinlymphoidmalignancies.Blood.2012Jan12;119(2):476-87.PMID:22080480.
FalconBL,BarrS,GokhalePC,etal.ReducedVEGFproduction,angiogenesis,andvascularregrowthcontributetotheantitumorpropertiesofdualmTORC1/mTORC2inhibitors.CancerRes.2011Mar1;71(5):1573-83.PMID:21363918.
VakanaE,SassanoA,PlataniasLC.InductionofautophagybydualmTORC1-mTORC2inhibitioninBCR-ABL-expressingleukemiccells.Autophagy.2010Oct;6(7):966-7.PMID:20699667.